While these cardiovascular benefits may be related to multiple mechanisms, including weight loss, the specific contribution of visceral fat reduction has not been definitively established
Safety, Tolerability and Sustained Weight Loss Over 2 Years With the Once-Daily Human GLP-1 Analog, Liraglutide
If a person has too little GLP-1, this may lead to a person eating more during meals or snacking between meals
Based on treating hundreds of patients with rapid weight changes, building in strength training and close dietary supervision gives you better health and body composition resultsnot just a lower number on the scale
Mei, J., Sun, J., Wu, J
Researchers are investigating genetic variants in GLP-1 receptor pathways, gut microbiome profiles, and baseline hormone levels to determine who will respond best to GLP-1 therapy, who might benefit from dual agonists, and who is more prone to side effects